# Health Catalyst (HCAT) — Earnings

HCAT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/hcat/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.04 |
| EPS estimate | $0.03 |
| EPS surprise | +33.78% |
| Revenue surprise | +2.02% |
| Revenue | $70.5M |
| Revenue estimate | $69.1M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1636422/000163642226000097/hcat-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/95d7d473-4bb3-c2ca-d1d6-56316fbf5d22.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | $0.03 | $0.04 | 33.78% | $69.1M | $70.5M |
| Q1 2026 | May 11, 2026 | $0.01 | $0.02 | 80.18% | $69.2M | $70.8M |
| Q4 2025 | Mar 12, 2026 | $0.09 | $0.08 | -15.07% | $74.0M | $74.7M |
| Q3 2025 | Nov 10, 2025 | $0.06 | $0.06 | -1.96% | $75.0M | $76.3M |
| Q2 2025 | Aug 7, 2025 | $0.03 | $0.04 | 22.32% | $80.6M | $80.7M |
| Q1 2025 | May 7, 2025 | −$0.00 | $0.01 | 470.37% | $79.2M | $79.4M |
| Q4 2024 | Feb 26, 2025 | $0.07 | $0.04 | -45.21% | $79.7M | $79.6M |
| Q3 2024 | Nov 6, 2024 | $0.10 | $0.07 | -27.39% | $76.3M | $76.4M |
| Q2 2024 | Aug 7, 2024 | $0.08 | $0.12 | 49.81% | $75.0M | $75.9M |
| Q1 2024 | May 9, 2024 | $0.03 | $0.05 | 62.34% | $74.8M | $74.7M |
| Q4 2023 | Feb 22, 2024 | $0.01 | $0.02 | 70.94% | $73.6M | $75.1M |
| Q3 2023 | Nov 2, 2023 | −$0.00 | $0.03 | 1171.43% | $73.0M | $73.8M |
| Q2 2023 | Aug 8, 2023 | −$0.01 | $0.05 | 562.96% | $72.6M | $73.2M |
| Q1 2023 | May 9, 2023 | −$0.04 | $0.05 | 235.87% | $71.2M | $73.9M |
| Q4 2022 | Feb 28, 2023 | −$0.11 | −$0.05 | 55.36% | $68.3M | $69.2M |
| Q3 2022 | Nov 8, 2022 | −$0.19 | −$0.13 | 31.43% | $66.8M | $68.4M |
| Q2 2022 | Aug 4, 2022 | −$0.10 | −$0.03 | 68.55% | $69.9M | $70.6M |
| Q1 2022 | May 10, 2022 | −$0.11 | −$0.06 | 43.98% | $66.0M | $68.1M |
| Q4 2021 | Mar 1, 2022 | −$0.21 | −$0.19 | 10.29% | $63.1M | $64.7M |
| Q3 2021 | Nov 9, 2021 | −$0.22 | −$0.18 | 17.20% | $60.8M | $61.7M |

## Frequently Asked Questions

### When did Health Catalyst (HCAT) last report earnings?

Health Catalyst last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did HCAT beat earnings estimates?

Yes. Health Catalyst reported EPS of $0.04 for Q2 2026 against a $0.03 estimate — a 33.78% beat.

### How much revenue did HCAT report last quarter?

Health Catalyst reported $70.5M in revenue for Q2 2026, against a consensus estimate of $69.1M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).